Optimising anti-TNF treatment using biosimilars
Non-response or loss of response to anti-TNFs in IBD: what’s the cause?
Non-response or loss-of response to anti-TNFs in IBD: what’s the cause?
Why does anti-TNF treatment of IBD lose effectiveness in up to 50% of patients? Find out more about the background of this condition and what can be done to manage patients better with an infographic on recent research on anti-TNFs in IBD.
Updates in your area
of interest
of interest
Articles your peers
are looking at
are looking at
Bookmarks
saved
saved
Days to your
next event
next event
This content has been developed independently of the sponsors who have had no editorial input into the content. Medthority received educational funding from the sponsor Biogen in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.